细胞毒性药物的契约製造市场：依生产规模、剂型、产品类型和地区划分。

预计到 2026 年，细胞毒性药物的契约製造市场规模将达到 126.065 亿美元，到 2033 年将达到 231.575 亿美元。预计从 2026 年到 2033 年，该市场将以 9.1% 的复合年增长率成长。

过去十年，细胞毒性药物的契约製造市场显着成长。癌症发病率的上升以及主要企业越来越多地采用各种成长策略（例如业务扩张、合作和收购），预计将在预测期内推动市场成长。製药和生物技术公司致力于细胞毒性药物和高活性药物原料药（HPAPI）的研发，既有自主生产，也有外包给其他製造商。

市场动态

预计癌症发生率的上升将推动预测期内的市场成长。例如，根据美国癌症协会的估计，2017年美国有1,688,780人被诊断出患有癌症，并报告了600,920例癌症死亡病例。

预计在预测期内，核准癌症治疗药物数量的不断增加将推动全球细胞毒性药物契约製造市场的成长。例如，2018年10月，Catalent Pharma Solutions公司生产的Verastem Oncology公司的COPIKTRA（Duvelisiv）胶囊获得了美国食品药物管理局（FDA）的核准。

此外，製药公司越来越多地采用契约製造服务预计将在预测期内推动全球细胞毒性药物契约製造市场的成长。例如，2018年9月，GB Sciences公司选择Catalent Pharma Solutions作为其合作伙伴，为其提供用于治疗帕金森氏症的专有活性药物成分（API）的口服给药系统、製剂开发和临床规模的口服生产服务。

本次调查的主要特点

• 本报告对细胞毒性药物的契约製造市场进行了详细分析，以 2025 年为基准年，给出了预测期（2026-2033 年）的市场规模和复合年增长率。
• 本报告指出了各个细分市场的潜在商机，并说明了该市场中具有吸引力的投资提案矩阵。
• 此外，本研究还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域展望以及主要企业采取的竞争策略的重要见解。
• 本报告根据以下参数对全球细胞毒性药物契约製造市场的主要企业进行了分析：公司概况、财务业绩、产品系列、市场地位、分销策略、主要发展、策略和未来计划。
• 透过利用本报告中提出的见解，企业行销负责人和经营团队将能够就未来的产品发布、技术升级、市场扩张和行销策略做出明智的决策。
• 本报告面向该产业的各类相关人员，包括投资者、供应商、产品製造商、经销商、新参与企业和金融分析师。
• 相关人员可以透过分析细胞毒性药物契约製造市场中使用的各种策略矩阵，更轻鬆地做出决策。

目录

第一章：研究目标与前提条件

• 研究目标
• 前提
• 简称

第二章 市场范围

• 报告摘要
  • 市场定义和范围
• 执行摘要
• Coherent Opportunity Map（COM）

第三章：市场动态、监管与趋势分析

• 市场动态
  • 促进因素
  • 抑制因子
  • 市场机会
• 影响分析
• 流行病学
• 市场趋势
• 产品发布
• 法规环境
• PEST分析
• 併购趋势
• 技术进步

第四章：全球细胞毒性药物契约製造市场：依生产规模划分，2026-2033年

• 工业规模
• 中试规模
• 实验室规模

第五章：全球细胞毒性药物契约製造市场：依剂型划分，2026-2033年

• 液体
• 固态的

第六章 全球细胞毒性药物契约製造市场：依产品类型划分，2026-2033年

• 口服
• 静脉注射

第七章 全球细胞毒性药物契约製造市场：依地区划分，2026-2033年

• 北美洲
  • 我们
  • 加拿大
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
• 欧洲
  • 德国
  • 英国
  • 法国
  • 义大利
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • ASEAN
  • 亚太其他地区
• 中东
  • 海湾合作委员会国家
  • 以色列
  • 其他中东国家
• 非洲
  • 南非
  • 中非
  • 北非

第八章 竞争情势

• 热图分析
• 市占率分析
  • Lonza Group
  • Piramal Group
  • Evonik Industries AG
  • Novasep Holding SAS
  • Merck KGaA（SAFC Pharma）
  • Baxter Biopharma Solutions
  • AbbVie Contract Manufacturing
  • Cambrex Corporation
  • CordenPharma International
  • BSP Pharmaceuticals SpA
  • Catalent, Inc.
  • Albany Molecular Research Inc.（AMRI）
  • Evotec
  • WuXi AppTec Co., Ltd.
  • Pierre Fabre Laboratories
  • Dishman Group

第九章

• 参考
• 调查方法

Cytotoxic Drugs Contract Manufacturing Market is estimated to be valued at USD 12,606.5 Mn in 2026 and is expected to reach USD 23,157.5 Mn by 2033, growing at a compound annual growth rate (CAGR) of 9.1% from 2026 to 2033.

Cytotoxic drugs contract manufacturing market has grown significantly over the last decade. Increasing incidence of cancer and increasing adoption of various growth strategies such as expansion, collaborations, and acquisitions by the key players are expected to boost market growth over the forecast period. Pharmaceutical and biotechnological companies are involved in research and development of cytotoxic drugs and high potency active pharmaceutical ingredients (HPAPIs), and in the manufacture of drugs in-house or outsource the production to other manufacturers.

Market Dynamics

Rising incidence of cancer is expected to propel the market growth over the forecast period. For instance, according to an American Cancer Society estimations, 2017, 1,688,780 people were estimated to be diagnosed with cancer and 600,920 cancer deaths were reported in the U.S.

Increasing product approval for the treatment of cancer is expected to boost growth of the global cytotoxic drugs contract manufacturing market over the forecast period. For instance, in October 2018, Catalent Pharma Solutions received the approval of U.S. Food and Drug Administration (FDA) for Verastem Oncology's COPIKTRA (duvelisib) capsules.

Furthermore, rising adoption of contract manufacturing services by the pharmaceutical companies is expected to drive growth of the global cytotoxic drugs contract manufacturing market over the forecast period. For instance, in September 2018, GB Sciences, Inc. selected Catalent Pharma Solutions to provide oral delivery systems, formulation development, and clinical-scale oral dose manufacturing of GB Sciences' proprietary active pharmaceutical ingredients (APIs) for its Parkinson's disease therapies.

Key features of the study

• This report provides in-depth analysis of the cytotoxic drugs contract manufacturing market and provides market size (USD Mn) and compound annual growth rate (CAGR %) for the forecast period (2026 - 2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global cytotoxic drugs contract manufacturing market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
• Key companies covered as part of this study include Lonza Group, Piramal Group, Evonik Industries AG, Novasep Holding SAS, Merck KGaA (SAFC Pharma), Baxter Biopharma Solutions, AbbVie Contract Manufacturing, Cambrex Corporation, BSP Pharmaceuticals S.p.A., CordenPharma International, Catalent, Inc., Albany Molecular Research Inc., Evotec, WuXi AppTec Co., Ltd., Pierre Fabre Laboratories, and Dishman Group
• Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding their future product launches, technology upgradation, market expansion, and marketing tactics
• The global cytotoxic drugs contract manufacturing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the cytotoxic drugs contract manufacturing market

Market Segmentation

• Production Scale Insights (Revenue, USD Mn, 2026 - 2033)
  • Industrial scale
  • Pilot Scale
  • Laboratory Scale
• Form Insights (Revenue, USD Mn, 2026 - 2033)
  • Liquid
  • Solid
• Product Type Insights (Revenue, USD Mn, 2026 - 2033)
  • Oral
  • Intravenous
• Regional Insights (Revenue, USD Mn, 2026 - 2033)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • Lonza Group
  • Piramal Group
  • Evonik Industries AG
  • Novasep Holding SAS
  • Merck KGaA (SAFC Pharma)
  • Baxter Biopharma Solutions
  • AbbVie Contract Manufacturing
  • Cambrex Corporation
  • BSP Pharmaceuticals S.p.A.
  • CordenPharma Internatisonal
  • Catalent, Inc.
  • Albany Molecular Research Inc.
  • Evotec
  • WuXi AppTec Co., Ltd.
  • Pierre Fabre Laboratories
  • Dishman Group

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Production Scale
  • Market Snippet, By Form
  • Market Snippet, By Product Type
  • Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Epidemiology
• Market Trends
• Product Launch
• Regulatory Scenario
• PEST Analysis
• Merger and Acquisition Scenario
• Technological Advancements

4. Global Cytotoxic Drugs Contract Manufacturing Market, By Production Scale, 2026 - 2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Industrial scale
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Pilot Scale
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Laboratory Scale
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends

5. Global Cytotoxic Drugs Contract Manufacturing Market, By Form, 2026 - 2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Liquid
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Solid
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends

6. Global Cytotoxic Drugs Contract Manufacturing Market, By Product Type, 2026 - 2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Oral
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Intravenous
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends

7. Global Cytotoxic Drugs Contract Manufacturing Market, By Region, 2026 - 2033, (USD Mn)

• Introduction
  • Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, For Region, 2021 - 2033
• North America
  • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
  • Y-o-Y Growth Analysis, For Country, 2021 - 2033
  • Market Size and Forecast, By Production Scale, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By Form, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By Product Type, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
    • U.S.
    • Canada
• Latin America
  • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
  • Y-o-Y Growth Analysis, For Country, 2021 - 2033
  • Market Size and Forecast, By Production Scale, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By Form, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By Product Type, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
  • Y-o-Y Growth Analysis, For Country, 2021 - 2033
  • Market Size and Forecast, By Production Scale, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By Form, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By Product Type, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
  • Y-o-Y Growth Analysis, For Country, 2021 - 2033
  • Market Size and Forecast, By Production Scale, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By Form, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By Product Type, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
  • Y-o-Y Growth Analysis, For Country, 2021 - 2033
  • Market Size and Forecast, By Production Scale, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By Form, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By Product Type, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
  • Y-o-Y Growth Analysis, For Country, 2021 - 2033
  • Market Size and Forecast, By Production Scale, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By Form, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By Product Type, 2026 - 2033, (USD Mn)
  • Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
    • South Africa
    • Central Africa
    • North Africa

8. Competitive Landscape

• Heat Map Analysis
• Market Share Analysis
  • Lonza Group
    • Company Overview
    • Form Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Piramal Group
    • Company Overview
    • Form Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Evonik Industries AG
    • Company Overview
    • Form Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Novasep Holding SAS
    • Company Overview
    • Form Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Merck KGaA (SAFC Pharma)
    • Company Overview
    • Form Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Baxter Biopharma Solutions
    • Company Overview
    • Form Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • AbbVie Contract Manufacturing
    • Company Overview
    • Form Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Cambrex Corporation
    • Company Overview
    • Form Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • CordenPharma International
    • Company Overview
    • Form Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • BSP Pharmaceuticals S.p.A.
    • Company Overview
    • Form Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Catalent, Inc.
    • Company Overview
    • Form Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Albany Molecular Research Inc. (AMRI)
    • Company Overview
    • Form Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Evotec
    • Company Overview
    • Form Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • WuXi AppTec Co., Ltd.
    • Company Overview
    • Form Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Pierre Fabre Laboratories
    • Company Overview
    • Form Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Dishman Group
    • Company Overview
    • Form Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Analyst Views

9. Section

• References
• Research Methodology
• About Us and Sales Contact